Add to ORKGObesity and resistance to insulin are closely associated with the development of low-grade inflammation. Interleukin 6 (IL-6) is linked to obesity-associated inflammation; however, its role in this context remains controversial. Here we found that mice wi
SummaryObesity-induced inflammation is critical for the development of insulin resistance. Here, we ...
SummaryInterleukin-6 (IL-6) plays a paradoxical role in inflammation and metabolism. The pro-inflamm...
Obesity is a metabolic disease characterized by a state of chronic, low-grade inflammation and domin...
Obesity and resistance to insulin are closely associated with the development of low-grade inflammat...
Interleukin (IL)-6 is an immuno-modulatory cytokine dysregulated in obesity and implicated in the de...
Interleukin-6 (IL-6) is a pleiotropic cytokine that exerts either proinflammatory or anti-inflammato...
The immune-modulating cytokine interleukin-6 (IL-6) its expressed both in adipose tissue and central...
SummaryThe contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains cont...
Aims/hypothesis The role of IL-6 in the development of obesity and hepatic insulin resistance is unc...
The contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains controversi...
Low-grade inflammation links obesity to insulin resistance through the activation of tissue-infiltra...
The contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains controversi...
It has been suggested that interleukin-6 (IL-6) produced by adipocytes in obesity leads to liver ins...
Chronic low-grade inflammation is a key driver of metabolic syndrome. This inflammatory response is ...
Summary: Interleukin (IL)-6 engages similar signaling mechanisms to leptin. Here, we find that centr...
SummaryObesity-induced inflammation is critical for the development of insulin resistance. Here, we ...
SummaryInterleukin-6 (IL-6) plays a paradoxical role in inflammation and metabolism. The pro-inflamm...
Obesity is a metabolic disease characterized by a state of chronic, low-grade inflammation and domin...
Obesity and resistance to insulin are closely associated with the development of low-grade inflammat...
Interleukin (IL)-6 is an immuno-modulatory cytokine dysregulated in obesity and implicated in the de...
Interleukin-6 (IL-6) is a pleiotropic cytokine that exerts either proinflammatory or anti-inflammato...
The immune-modulating cytokine interleukin-6 (IL-6) its expressed both in adipose tissue and central...
SummaryThe contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains cont...
Aims/hypothesis The role of IL-6 in the development of obesity and hepatic insulin resistance is unc...
The contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains controversi...
Low-grade inflammation links obesity to insulin resistance through the activation of tissue-infiltra...
The contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains controversi...
It has been suggested that interleukin-6 (IL-6) produced by adipocytes in obesity leads to liver ins...
Chronic low-grade inflammation is a key driver of metabolic syndrome. This inflammatory response is ...
Summary: Interleukin (IL)-6 engages similar signaling mechanisms to leptin. Here, we find that centr...
SummaryObesity-induced inflammation is critical for the development of insulin resistance. Here, we ...
SummaryInterleukin-6 (IL-6) plays a paradoxical role in inflammation and metabolism. The pro-inflamm...
Obesity is a metabolic disease characterized by a state of chronic, low-grade inflammation and domin...